“Our results provide the first pieces of evidence that early so called epigenetic programming of the immune system during birth may have a role to play”, says Professor Mikael Norman at the Department of Clinical Science, Intervention and Technology.

Caesarean section delivery is rapidly increasing worldwide and is currently the most common surgical procedure among women of child-bearing age. Until recently, the long-term consequences of this mode of delivery had not been studied. It is now thought that early genetic changes could explain why people delivered by Caesarean section in later life are more susceptible to immunological diseases such as diabetes, asthma or leukaemia than those born by normal vaginal deliveries.

In the presented study, blood was sampled from the umbilical cords of 37 newborn infants just after delivery and then again three to five days after the birth. The blood samples were analysed to see the degree of DNA-methylation (chemical altering of the DNA) in the white blood cells, a vital part of the immune system. This showed that the 16 babies born by Caesarean section exhibited higher DNA-methylation rates immediately after delivery than the 21 born by vaginal delivery. Three to five days after birth, DNA-methylation levels had dropped in infants delivered by Caesarean section so that there were no longer significant differences between the two groups.

The researchers point out, that the reason why DNA-methylation is higher after Caesarean section deliveries still is unclear and that further research is needed.

“Although we do not know yet how specific gene expression is affected after Caesarean section deliveries, or to what extent these genetic differences related to mode of delivery are long-lasting, we believe that our findings open up a new area of important clinical research” concludes lead author Titus Schlinzig, a research fellow at Karolinska Institutet.

Publication: ‘Epigenetic modulation at birth – altered DNA-methylation in white blood cells after Caesarean section’, Schlinzig T, Johansson S, Gunnar A, Ekström TJ, Norman M., Acta Paediatrica 2009, 98, 1096-99 (Invited commentary on pp 1082-84 in same issue of the journal).

For further questions, please contact:

Professor Mikael Norman
Department of Clinical Science, Intervention and Technology
Tel: +46 (0)8-585 810 65,
Mobile: +46 (0)73-620 45 96
E-mail: Mikael.Norman@ki.se

Press Officer Sabina Bossi
Tel: +46 (0)8-524 860 66
Mobile: +46 (0)70-614 60 66
Email: sabina.bossi@ki.se

Karolinska Institutet

Karolinska Institutet is one of the leading medical universities in Europe. Through research and education, Karolinska Institutet contributes to improving human health. Each year, the Nobel Assembly at Karolinska Institutet awards the Nobel Prize in Physiology or Medicine. For more information, visit ki.se.